Skip to content
Research Article Open access CC BY 3.0

Prevalence and Antimicrobial Susceptibility Pattern of Methicillin-Resistant Staphylococcus aureus and Coagulase-Negative Staphylococci in Rawalpindi, Pakistan

Irum Perveen, Abdul Majid, Sobia Knawal, Iffat Naz, Shama Sehar, Safia Ahmed, Muhammad Asam Raza

Journal of Advances in Medicine and Medical Research · pp. 198–209 · Published 9 Jan 2013

10.9734/BJMMR/2013/2109

Abstract

Methicillin resistant Staphylococcus aureus (MRSA) and methicillin resistant coagulase negative staphylococci (MRCoNS) are the important nosocomial infectious agents. There is a growing concern about the rapid rise in the resistance of Staphylococcus aureus to presently available antimicrobial agents. The aim of this study was to evaluate the prevalence rate of MRSA and MRCoNS and their rate of resistance to different antistaphylococcal antibiotics used broadly for treatment. Out of the total 350 staphylococcal isolates from different clinical specimens 148 isolates (60.40%) were identified as MRSA by oxacillin screen agar method, and 46 isolates (43.80%) were screened as MRCoNS. All the MRSA and MRCoNS isolates were tested for antibiotic resistance pattern by disc diffusion method for 16 different antibiotics. All the isolates of MRSA and MRCoNS were multi-drug resistant. Antibiotic resistance pattern of these isolates was high against penicillin. All the MRSA strains were resistant to penicillin and oxacillin (100%), followed by cephalothin and nalidixic acid (89.18%), cotrimoxazole (86.48%), erythromycin (85.81%), cephalaxin and cephradine (83.10%), levofloxacin (80.40%), imipenem (77.70%), gentamicin (76.35%), tetracycline (59.45%), ciprofloxacin (44.59%), chloramphenicol (18.24%) and rifampicin (10.13%). The MRCoNS strains also showed closely similar drug resistance pattern with 97.82% isolates being resistant to penicillin, followed by oxacillin (95.65%), cephalothin (86.95%), cephradine (82.60%), levofloxacin and nalidixic acid (80.43%), erythromycin, cephalaxin and imipenem (78.26%), cotrimoxazole (73.91%), gentamicin (69.56%), ciprofloxacin and tetracycline (63.04%), chloramphenicol (13.04%) and rifampicin (6.52%). However, all the MRSA and MRCoNS isolates, even those with very high oxacillin MIC (>130 µg/ml) were uniformly susceptible to vancomycin. Chloramphenicol and rifampicin also showed excellent activity against methicillin-resistant isolates. Overall, data presented in this study indicated a slightly higher methicillin resistant rate in MRSA compared to MRCoNS strains. Multi-drug resistance rates in our MRSA and MRCoNS isolates were, 58.10 and 32.60%, respectively. Application of ß-lactamase production method revealed that 84% of MRSA and 87% of MRCoNS strains tested positive for the ß-lactamase production. This study indicated a high level prevalence of MRSA and MRCoNS strains resistance against widely used antimicrobial agents. An appropriate knowledge on the current antibiotic susceptibility pattern of MRSA and MRCoNS is essential for appropriate therapeutic regime determination.

MRSA MRCoNS multidrug resistance prevalence antibiotic susceptibility MIC.

References (63)

  1. 1 Antibiotic Susceptibility Testing by a Standardized Single Disk Method [DOI]
  2. 2 Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks [DOI]
  3. 3 Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department [DOI]
  4. 4 Comparison of Mortality Associated with Methicillin‐Resistant and Methicillin‐Susceptible Staphylococcus aureus Bacteremia: A Meta‐analysis [DOI]
  5. 5 Community-Acquired Methicillin-ResistantStaphylococcus aureusCarrying Panton-Valentine Leukocidin Genes: Worldwide Emergence [DOI]
  6. 6 Community-associated meticillin-resistant Staphylococcus aureus [DOI]
  7. 7 Community-Acquired Methicillin-Resistant Staphylococcus aureus in Children With No Identified Predisposing Risk [DOI]
  8. 8 Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin [DOI]
  9. 9 Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network [DOI]
  10. 10 Methicillin-ResistantStaphylococcus aureus in Europe [DOI]
  11. 11 Methicillin-resistantStaphylococcus aureusin Europe, 1999–2002 [DOI]
  12. 12 The Economic Impact of Staphylococcus aureus Infection in New York City Hospitals [DOI]
  13. 13 The Arginine Catabolic Mobile Element and Staphylococcal Chromosomal CassettemecLinkage: Convergence of Virulence and Resistance in the USA300 Clone of Methicillin‐ResistantStaphylococcus aureus [DOI]
  14. 14 Community-Associated MRSA — Resistance and Virulence Converge [DOI]
  15. 15 Prevalence of nosocomial infections in neonatal intensive care unit patients: Results from the first national point-prevalence survey [DOI]
  16. 16 Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversification [DOI]
  17. 17 Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50 [DOI]
  18. 18 Community‐Acquired Methicillin‐Resistant Staphylococcus aureus in Hospitalized Adults and Children without Known Risk Factors [DOI]
  19. 19 A Proteolytic Transmembrane Signaling Pathway and Resistance to β-Lactams in Staphylococci [DOI]
  20. 20 Community‐Associated Methicillin‐ResistantStaphylococcus aureus [DOI]
  21. 21 Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey [DOI]
  22. 22 Prevalence of methicillin resistant Staphylococcus aureus in a tertiary referral hospital in eastern Uttar Pradesh.
  23. 23 Comparisons of Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Hospital-Associated MSRA Infections in Sacramento, California [DOI]
  24. 24 Community-Associated Methicillin-Resistant Staphylococcus aureus [DOI]
  25. 25 Community associated methicillin-resistant Staphylococcus aureus. [DOI]
  26. 26 A Novel Methicillin‐Resistance Cassette in Community‐Acquired Methicillin‐ResistantStaphylococcus aureusIsolates of Diverse Genetic Backgrounds [DOI]
  27. 27 Managing methicillin-resistant staphylococci: A paradigm for preventing nosocomial transmission of resistant organisms [DOI]
  28. 28 EMERGENCE OF LOW LEVEL VANCOMYCIN RESISTANCE IN MRSA [DOI]
  29. 29 Bacterial Resistance to Antimicrobials [DOI]
  30. 30 Detection of methicillin resistance in Staphylococcus aureus isolated from pediatric patients: is the cefoxitin disk diffusion test accurate enough? [DOI]
  31. 31 The Evolving Epidemiology of Methicillin-Resistant Staphylococcus aureus at a University Hospital [DOI]
  32. 32 Alteration of Cutaneous Staphylococcal Flora as a Consequence of Antimicrobial Prophylaxis [DOI]
  33. 33 In Vitro Activities of Ceftobiprole, Tigecycline, Daptomycin, and 19 Other Antimicrobials against Methicillin-Resistant Staphylococcus aureus Strains from a National Survey of Belgian Hospitals [DOI]
  34. 34 Methicillin resistance among isolates of Staphylococcus aureus: antibiotic sensitivity pattern & phage typing.
  35. 35 Antibiotic susceptibility profile of methicillin-resistant staphylococci isolated from nasal samples of hospitalized patients [DOI]
  36. 36 Community-Associated Methicillin-Resistant Staphylococcus aureus [DOI]
  37. 37 Efficacy of Vancomycin Plus Rifampin in Experimental Aortic-Valve Endocarditis Due to Methicillin-Resistant Staphylococcus aureus: In Vitro-in Vivo Correlations [DOI]
  38. 38 ANTISTAPHYLOCOCCAL (MSSA, MRSA, MSSE, MRSE) ANTIBIOTICS [DOI]
  39. 39 Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in latin American hospitals: Results from the SENTRY antimicrobial surveillance program, 1997-98 [DOI]
  40. 40 Reconsideration of Rifampin [DOI]
  41. 41 Correlation between Genotype and Phenotypic Categorization of Staphylococci Based on Methicillin Susceptibility and Resistance [DOI]
  42. 42 Ampicillin, Sulbactam, and Rifampin Combination Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Endocarditis in Rabbits [DOI]
  43. 43 An econometric view of the dynamic relationship between antibiotic consumption, hand disinfection and methicillin-resistant Staphylococcus aureus [DOI]
  44. 44 MRSA: total war or tolerance? [DOI]
  45. 45 Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone [DOI]
  46. 46 In vitro synergy between cefepime and vancomycin against methicillin-susceptible and -resistant Staphylococcus aureus and Staphylococcus epidermidis [DOI]
  47. 47 Type Frequency and Antimicrobial Susceptibility ofMycobacterium avium-intracellulareComplex Strains Isolated in Italy from AIDS and Non-AIDS Patients [DOI]
  48. 48 In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci [DOI]
  49. 49 Antibiogram Sensitivity Pattern of Methicillin-resistant Staphylococcus aureus Isolates from Pus Samples [DOI]
  50. 50 Staphylococcus aureus Infections [DOI]
  51. 51 Diagnostic Microbiology. [DOI]
  52. 52 Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department [DOI]
  53. 53 Antibacterial resistance [DOI]
  54. 54 Methicillin resistant Staphylococcus aureus: a multicentre study.
  55. 55 THE CURRENT SUSCEPTIBILITY PATTERNS OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS TO CONVENTIONAL ANTI STAPHYLOCOCCUS ANTIMICROBIALS AT RAWALPINDI
  56. 56 Managing Methicillin-Resistant Staphylococci: A Paradigm for Preventing Nosocomial Transmission of Resistant Organisms [DOI]
  57. 57 Antimicrobial Susceptibility and Beta-lactamase detection of MRSA in Osogbo. SW Nigeria
  58. 58 Bacterial Resistance to Antimicrobials [DOI]
  59. 59 The Evolving Epidemiology of Methicillin-Resistant Staphylococcus aureus at a University Hospital [DOI]
  60. 60 A Rapid Slide Test for Penicillinase [DOI]
  61. 61 Staphylococcus Aureus Infection [DOI]
  62. 62 Bacterial Resistance to Antimicrobials [DOI]
  63. 63 Control of infection.

Cited by 42

High prevalence of panton-valentine leukocidin in methicillin-resistant Staphylococcus aureus in a tertiary care hospital in Peshawar, Pakistan

· International Journal of Biosciences (IJB) · 2019

Exploring the incidence potential of phenol-soluble modulins among methicillin-resistant Staphylococcus aureus in Lahore, Pakistan

Sourat Mudassar, Abida Bano, Farah Asghar · BMC Infectious Diseases · 2025

Molecular analysis of Panton-Valentine Leucocidin (pvl) gene among MRSA and MSSA isolates

H. Tabassum, M. Gull, A. Rasheed · Brazilian Journal of Biology · 2023

Molecular Epidemiology and Mechanisms of Antibiotic Resistance in Gram-positive Bacteria in Africa: A Systematic Review and Meta-Analysis from a One Health Perspective

John Osei Sekyere, JEric Mensah · 2018

Incidence of Vancomycin Resistant Phenotype of the Methicillin Resistant Staphylococcus aureus Isolated from a Tertiary Care Hospital in Lahore

Aqib Saeed, Fatima Ahsan, Muhammad Nawaz · Antibiotics · 2019

Self-Assembled PtII8 Metallosupramolecular Tubular Cage as Dual Warhead Antibacterial Agent in Water

Soumalya Bhattacharyya, Mangili Venkateswarulu, Jagabandhu Sahoo · Inorganic Chemistry · 2020

Degree of bacterial contamination in barbershops using hair dryers in Riyadh

Sulaiman A. Al Yousef · Saudi Journal of Biological Sciences · 2021

Antibiotic sensitivity pattern and cost-effectiveness analysis of antibiotic therapy in an Indian tertiary care teaching hospital

Shamungum Sriram, Varghese Aiswaria, AnnieEapen Cijo · Journal of Research in Pharmacy Practice · 2013

Prevalence and investigations of bacterial contamination in dental healthcare associated environment

Ghadah Salim Abusalim · Journal of King Saud University - Science · 2022

Study on Multi Drug Resistant Opportunistic Pathogens Obtained from Clinical Settings of Tamil Nadu for Developing Novel Alternative Therapeutics

Rajendran Venkatasubramani, Thirumoorthy Viswanathan · Journal of Pure and Applied Microbiology · 2019

Showing 16 of 42 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

64

Page views

0

PDF downloads

18

Outbound clicks

42

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.